Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Microbial Limit Testing of Ointments – V 2.0

Posted on By

SOP for Microbial Limit Testing of Ointments – V 2.0

Procedure for Microbial Limit Testing of Ointments

Department Quality Control (QC)/Microbiology/Quality Assurance (QA)
SOP No. SOP/Ointment/063
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a standardized method for microbial limit testing of ointments to ensure compliance with microbiological safety standards and Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all personnel in the Quality Control (QC) and Microbiology departments responsible for conducting microbial limit testing of ointments during formulation development, in-process control, and final batch release.

3. Responsibilities

  • Microbiologist: Conducts microbial limit testing and records results.
  • Quality Control Analyst: Reviews and compiles test results.
  • Quality Assurance Personnel: Verifies and approves microbial limit test reports.
  • Production Supervisor: Ensures that the ointment batches conform to microbial safety requirements.

4. Accountability

The QC, Microbiology, and QA Managers are accountable for ensuring that microbial limit tests are conducted accurately and documented as per regulatory and GMP standards.

See also  Ointments: SOP for Cleaning Utensils Used in Ointment Manufacturing - V 2.0

5. Procedure

5.1 Equipment and Materials

  • Sterile sampling containers
  • Sterile diluents (e.g., phosphate buffer, peptone water)
  • Nutrient agar, MacConkey agar, Sabouraud dextrose agar
  • Sterile pipettes and micropipettes
  • Incubators set at 30°C – 35°C for bacteria and 20°C – 25°C for fungi
  • Laminar airflow hood
  • Sterile filtration system (if required)
  • Colony counter

5.2 Sample

Preparation
  • Collect the sample aseptically in a sterile container.
  • Weigh 10 g of the ointment sample.
  • Mix with 90 mL of sterile phosphate buffer or other suitable diluent to create a 1:10 dilution.
  • Further dilutions (1:100, 1:1000) may be prepared based on the microbial limit specifications.

5.3 Test Methods

5.3.1 Total Aerobic Microbial Count (TAMC)

  • Transfer 1 mL of diluted sample onto sterile nutrient agar plates.
  • Spread evenly using a sterile glass spreader.
  • Incubate plates at 30°C – 35°C for 48 – 72 hours.
  • Count the number of colonies and record the results in CFU/g.

5.3.2 Total Yeast and Mold Count (TYMC)

  • Transfer 1 mL of diluted sample onto sterile Sabouraud dextrose agar plates.
  • Spread evenly and incubate at 20°C – 25°C for 5 – 7 days.
  • Count the yeast and mold colonies and record the results in CFU/g.

5.3.3 Pathogen Testing

  • For detection of Escherichia coli:
    • Transfer 1 mL of diluted sample onto MacConkey agar plates.
    • Incubate at 30°C – 35°C for 24 – 48 hours.
    • Check for lactose fermenting colonies.
  • For detection of Staphylococcus aureus:
    • Transfer 1 mL of diluted sample onto Mannitol salt agar.
    • Incubate at 30°C – 35°C for 24 – 48 hours.
    • Check for yellow colonies indicating S. aureus.
  • For detection of Pseudomonas aeruginosa:
    • Transfer 1 mL of diluted sample onto cetrimide agar.
    • Incubate at 30°C – 35°C for 24 – 48 hours.
    • Check for greenish-blue colonies.

5.4 Acceptance Criteria

  • Total Aerobic Microbial Count (TAMC) should not exceed 1000 CFU/g.
  • Total Yeast and Mold Count (TYMC) should not exceed 100 CFU/g.
  • Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa must be absent in 1 g of sample.

5.5 Documentation

  • Record all microbial counts in the Microbial Limit Test Log.
  • Document incubation conditions, sample preparation, and culture media used.
  • QA personnel must review and approve results before batch release.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • TAMC – Total Aerobic Microbial Count
  • TYMC – Total Yeast and Mold Count
  • CFU – Colony-Forming Units

7. Documents

  • Microbial Limit Test Log (Annexure-1)
  • Ointment Batch Microbial Report (Annexure-2)

8. References

  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • USP <61> – Microbial Enumeration Tests
  • USP <62> – Tests for Specified Microorganisms
  • ICH Q2 (R1) – Validation of Analytical Procedures

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Microbial Limit Test Log

Date Batch Number TAMC (CFU/g) TYMC (CFU/g) Pathogen Results Verified By
01/02/2025 OINT-101 800 50 Absent QA Officer
02/02/2025 OINT-102 950 60 Absent QA Officer

12. Revision History:

Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Tablets: SOP for Optimizing Surface Coating Uniformity – V 2.0
Next Post: SOP for Preparing Prototype Formulations for Testing

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

English
 - 
en
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version